Novo Nordisk executive Gordon Findlay collapsed behind President Donald Trump during an Oval Office press conference on Thursday with drugmakers to expand coverage and reduce prices for popular obesity treatments Zepbound and Wegovy.
Findlay was identified by several members of the press covering the announcement.
Officials rushed to help him after his collapse, and the press was quickly removed. It was unclear what caused the collapse.
White House press secretary Karoline Leavitt said in a statement, “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Loading twitter content…
This is a breaking news story. Updates to follow.
